AmerisourceBergen Acquires PharmaLex for €1.28B

PharmaLex Acquires Arbour Group from Keystone Capital

February 12, 2020

Healthcare Services

The PharmaLex Group has acquired Arbour Group, LLC from Keystone Capital. The acquisition expands PharmaLex’s regulatory compliance, quality management and connected health capabilities and strengthens its presence in the United States.

PharmaLex Group Merges with NeoHealthHub Limited

October 13, 2022

Healthcare Services

PharmaLex Group has merged with UK-based NeoHealthHub Limited to strengthen PharmaLex’s market access and data capabilities in the UK and build a pan‑European market access practice. NeoHealthHub, headquartered in Lutterworth, Leicestershire, employs around 50 people and will expand PharmaLex’s local market access, data and capability development offerings across major European markets.

Bruker Corporation to Acquire PhenomeX Inc for $108 Million

August 17, 2023

Medical Devices

Bruker Corporation has signed a definitive agreement to acquire PhenomeX Inc in an all-cash transaction valued at approximately $108 million equity value ($1.00 per share). The deal is expected to close in the fourth quarter of 2023, subject to customary closing conditions, after which PhenomeX will merge into a wholly owned Bruker subsidiary.

ProPharma Group Acquires Pharmica Consulting

October 6, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.

KELIX bio to Acquire Pharmaceutical Institute (PHI) in Rabat, Morocco

March 8, 2022

Pharmaceuticals

KELIX bio, a pan-African biopharmaceutical platform, entered into a binding commitment to acquire Pharmaceutical Institute (PHI), a leading pharmaceutical manufacturer in Rabat, Morocco. The deal marks KELIX bio’s first entry into Morocco and is intended to strengthen the company’s manufacturing and distribution presence as Morocco expands universal health coverage.

Pharmaron Acquires 82.54% of Biortus Biosciences

October 28, 2025

Healthcare Services

Pharmaron Beijing Co., Limited has entered into a definitive Share Purchase Agreement to acquire 82.54% of Biortus Biosciences Co., Ltd. and its affiliates. The transaction is expected to close after satisfaction of customary closing conditions and is intended to strengthen Pharmaron’s structure-based drug discovery and protein science capabilities.